CBE ID
3722
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
Next Planned Maintenance Review
Fall 2027
1.3 Measure Description
Percent of all dialysis patient-months in the measurement year in which the patient was dialyzing via a home dialysis modality.
-
-
1.5 Measure Type
-
1.14 Numerator
Patient-months from the denominator in which the patient was dialyzing via a home modality (peritoneal dialysis and/or home hemodialysis) as of the final dialysis treatment of the given measurement month.
-
1.15 Denominator
All dialysis patient-months (in-center and/or home) attributed to the dialysis facility (or aggregate HRR unit) during the measurement year.
-
1.13a Data dictionary not attachedNoOLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityNot Endorsed Renal Fall 2022Initial EndorsementLast Updated
-
StewardSteward Organization EmailMeasure Developer Secondary Point Of Contact
United States
-
-
-
Risk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #3722, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/3722.zip
Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.